Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L6 pseudogene 5 (RPL6P5)
- Target
- RPL6P5
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L6 pseudogene 5 (RPL6P5) is a non-coding, processed pseudogene derived from the ribosomal protein L6 locus. It does not encode a functional protein, has no known biological or disease role, and is not druggable or considered a therapeutic target in biomedical research[3][5].
- Other names
- RPL6_4_280RPL6P5
Beyond the preview
Go deeper on Ribosomal protein L6 pseudogene 5 (RPL6P5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L6 pseudogene 5 (RPL6P5).